# A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

> **NCT06676007** · — · RECRUITING · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 200 (estimated)

## Conditions studied

- IgA Nephropathy (IgAN)
- Early Initial Therapy

## Interventions

- **OTHER:** Gd-IgA1 test

## Key facts

- **NCT ID:** NCT06676007
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06676007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06676007, "A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06676007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*